Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Adedoyin Agbabiaka
Institution:
Nigerian Institute of Medical Research
Observed institution:
Nigerian Institute of Medical Research
OpenAlex ID:
A5119135807
Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial
2025
·
Abideen Salako
, Adesola Musa
, et al.
·
Scientific Reports
·
2
PDF
A triple-blinded randomized control trial to evaluate the safety and immunogenicity of fractional doses of COVID-19 vaccines (ChAd0x1, AD26.COV2. S, and BNT162B2) among Nigeria adults: the SIFCoVAN trial
2025
·
Adesola Zaidat Musa
, Abideen Olurotimi Salako
, et al.
·
Trials
Correction: Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial
2025
·
Abideen Salako
, Adesola Musa
, et al.
·
Scientific Reports
PDF
Show more works
View as search
Works count:
3
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type
